Ferumoxtran-10

N/A

Report date: 2025/09/29 17:55:10

Base Information

Drug NameFerumoxtran-10
Drug Alias NameUSPIOFerumoxtran-10 dextran-coatedDextran-coated ultrasmall superparamagnetic iron oxideCombidexFerrotran +[11] 
ClassificationDiagnostic agent (In vivo)Small moleculesDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAortic AneurysmNeoplasm MetastasisUrinary Bladder Neoplasms +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAmag Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNanoEcho ABSanochemia Pharmazeutika GmbHUniversity Health Network (Uhn)
Inactive CompaniesSaving Patients' Lives Medical BvRadboud University Medical CenterOhsu Knight Cancer Institute +[6] 
Active IndicationsUrinary Bladder NeoplasmsProstatic NeoplasmsUterine Cervical Neoplasms +[5] 
Inactive IndicationsAortic AneurysmNeoplasm MetastasisEndometrial Neoplasms +[8] 

Other Information

ATC CodeN/A
Related LinksN/A